利干德制药 LGND
$306.20 +$7.20 (+2.41%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $308.00 +0.59%
开盘$302.02
昨收$299.00
当日区间$297.84 – $308.26
成交量133.0K
市值$6.12B
市盈率（TTM）123.0
股息率–
LGND 相关新闻
匹配 Ligand Pharmaceuticals 或代码 LGND 的头条新闻，按最新排序。
- Barclays Initiates Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $345
- Citi Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $397
- H.C. Wainwright Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $358
- Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating
- A Quick Look at Today's Ratings for Ligand Pharmaceuticals(LGND.US), With a Forecast Between $388 to $397
- A Quick Look at Today's Ratings for Ligand Pharmaceuticals(LGND.US), With a Forecast Between $326 to $370
- RBC Capital Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $345 正面
- H.C. Wainwright Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $358 正面
- Oppenheimer Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $326 正面
- Stifel Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $332
- Citi Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $390 正面
- RBC Capital Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $345
- BofA Securities Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $388 正面
- Stifel Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $332 正面
- BofA Securities Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $388
暂无评论——快来第一个聊聊 LGND。
登录后参与讨论。